Nomura Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Nomura Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$922K	Hold	4,846	–	–	﹤0.01%	759
2026 Q1	$818K	Hold	4,846	–	–	﹤0.01%	775
2025 Q4	$818K	Hold	4,846	–	–	﹤0.01%	770
2025 Q3	$700K	Buy	+4,846	New	+$661K	﹤0.01%	776
2024 Q4	–	Sell	-24,400	Closed	-$3.55M	–	1501
2024 Q3	$3.55M	Hold	24,400	–	–	0.01%	650
2024 Q2	$3.35M	Sell	24,400 -3,482	-12%	-$465K	0.01%	629
2024 Q1	$3.83M	Buy	27,882 +7,482	+37%	+$1.02M	0.01%	599
2023 Q4	$2.77M	Buy	+20,400	New	+$2.49M	0.01%	661
2022 Q1	–	Sell	-9,680	Closed	-$1.48M	–	1562
2021 Q4	$1.48M	Buy	+9,680	New	+$1.5M	0.01%	804
2018 Q2	–	Sell	-11,194	Closed	-$1.2M	–	953
2018 Q1	$1.2M	Buy	+11,194	New	+$1.24M	0.01%	685
2017 Q4	–	Sell	-10,893	Closed	-$1.21M	–	942
2017 Q3	$1.21M	Buy	+10,893	New	+$1.16M	0.02%	637
2016 Q2	–	Sell	-5,550	Closed	-$483K	–	1132
2016 Q1	$483K	Buy	+5,550	New	+$496K	0.01%	801

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Nomura Asset Management's IBB Position: Q2 2026 in Review

Nomura Asset Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 4,846 shares worth $922K. The position accounts for ﹤0.01% of the portfolio, ranked #759.

Nomura Asset Management first reported a position in IBB in Q1 2016 and has held it in 12 quarters since. The position peaked at $3.83M in Q1 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Nomura Asset Management held 4,846 shares of iShares Biotechnology ETF worth $922K as of Q2 2026.
Nomura Asset Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Nomura Asset Management's portfolio in Q2 2026, its #759 holding.
Nomura Asset Management first reported a position in iShares Biotechnology ETF in Q1 2016 and has held it in 12 quarters since.
Nomura Asset Management's iShares Biotechnology ETF position peaked at $3.83M in Q1 2024.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.